Hepatitis B Trial, Recruiting (NCT07540637)

Hepatitis B Trial, Recruiting NCT07540637 Sponsor: Institute of Gastroenterology and Hepatology, Vietnam Condition: Hepatitis B

Printed from Voxsanity (voxsanity.com.au) — NCT07540637 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hepatitis B

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older.
You have been diagnosed with Chronic Hepatitis B, meaning a specific protein (HBsAg) or the hepatitis B virus has been detected in your blood for 6 months or more, or you have had a positive HBsAg test with a negative IgM antibody result (confirm with trial site).
You own a smartphone (iPhone or Android) with an internet connection and are able to install a health app called HBVCare.
You are able to read, understand, and respond to questions written in Vietnamese.
You are willing to give your formal agreement to take part in the study.

Who may not be able to join:

You have a mental health condition, memory or thinking difficulties, or trouble communicating or using a mobile phone app.
You have a serious long-term health condition such as heart failure, kidney failure, or severe breathing problems.
You currently have serious complications such as bleeding in the digestive system, liver cancer, confusion caused by liver problems (hepatic encephalopathy), or sudden severe liver failure.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +84796262002

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07540637

Sponsor: Institute of Gastroenterology and Hepatology, Vietnam

Phase: Not Applicable

Status: Recruiting

Condition: Hepatitis B

Trial contact: +84796262002

More information: https://clinicaltrials.gov/study/NCT07540637

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older.
You have been diagnosed with Chronic Hepatitis B, meaning a specific protein (HBsAg) or the hepatitis B virus has been detected in your blood for 6 months or more, or you have had a positive HBsAg test with a negative IgM antibody result (confirm with trial site).
You own a smartphone (iPhone or Android) with an internet connection and are able to install a health app called HBVCare.
You are able to read, understand, and respond to questions written in Vietnamese.
You are willing to give your formal agreement to take part in the study.

Who may not be able to join:

You have a mental health condition, memory or thinking difficulties, or trouble communicating or using a mobile phone app.
You have a serious long-term health condition such as heart failure, kidney failure, or severe breathing problems.
You currently have serious complications such as bleeding in the digestive system, liver cancer, confusion caused by liver problems (hepatic encephalopathy), or sudden severe liver failure.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Institute of Gastroenterology and Hepatology, Vietnam

Registry

ClinicalTrials.gov

Start date

15 April 2026

Est. completion

30 November 2026

Where this trial is recruiting

🇻🇳 Vietnam

Primary endpoints

Proportion of patients with good treatment adherence at 3 months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov